Introduction to Piqray (Alpelisib) 150mg
Piqray (Alpelisib) 150mg is a prescription medicine used in the treatment of advanced or metastatic breast cancer with PIK3CA mutations. This medicine belongs to a class of targeted oncology drugs that inhibit the PI3K-alpha pathway, which plays a key role in cancer cell growth and survival.
Piqray (Alpelisib) 150mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Targeted Cancer Therapies. It contains Alpelisib, which works by blocking the PI3K-alpha enzyme, slowing tumor progression and enhancing the effects of hormonal therapy.
In some markets, Alpesib 150mg is available as a generic brand containing the same active ingredient Alpelisib, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.
What Is Piqray (Alpelisib)?
Piqray is the original brand name for Alpelisib, an oral targeted therapy used for the treatment of advanced or metastatic breast cancer with confirmed PIK3CA mutations.
Alpelisib belongs to a class of medicines known as PI3K-alpha inhibitors, which block abnormal signaling pathways that promote tumor growth.
Generic versions such as Alpesib 150mg contain the same active compound and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Alpelisib is classified as a PI3K-alpha inhibitor with targeted antineoplastic properties.
How Alpelisib Works
It works in several ways:
- Blocks PI3K-alpha enzyme activity in cancer cells
- Inhibits abnormal cell proliferation and survival
- Enhances the efficacy of hormone therapy in breast cancer
Through these mechanisms, Alpelisib helps slow tumor progression in PIK3CA-mutated breast cancers.
How Piqray Works in the Body
PIK3CA-mutated breast cancer cells rely on the PI3K-alpha signaling pathway to grow and survive. Piqray selectively inhibits this pathway.
Key Actions of Alpelisib
- Inhibits PI3K-alpha signaling in tumor cells
- Reduces cancer cell proliferation
- Enhances response to hormonal therapies in HR-positive, HER2-negative breast cancer
Some generic versions such as Alpesib deliver the same active compound, allowing similar targeted therapy when prescribed appropriately.
Medical Uses of Piqray (Alpelisib) 150mg
Piqray 150mg is prescribed for adult patients with HR-positive, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer.
Piqray for Breast Cancer
For patients with PIK3CA-mutated breast cancer, Piqray is used in combination with hormone therapy such as fulvestrant.
Potential Benefits
- Targets PIK3CA mutations specifically
- Slows disease progression
- Improves outcomes when combined with hormonal therapy
Who Can Take Alpesib 150mg?
Because Alpelisib is a potent targeted therapy, treatment should always be supervised by an experienced oncologist.
Eligibility Criteria
Patients may be prescribed Piqray if they:
- Have HR-positive, HER2-negative, PIK3CA-mutated breast cancer
- Are undergoing hormonal therapy for advanced disease
- Can adhere to regular monitoring for blood sugar and liver function
Certain generic options such as Alpesib may also be considered depending on availability and physician decision.
Who Should Avoid Piqray (Alpelisib) 150mg
Piqray should NOT be used by:
- Pregnant or breastfeeding women
- Individuals with hypersensitivity to Alpelisib
- Patients with uncontrolled diabetes or severe liver impairment without supervision
Piqray (Alpelisib) 150mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- Piqray 150mg orally once daily
- Tablets should be taken with food
- Can be combined with hormone therapy as prescribed
- Treatment continues as long as clinical benefit is observed
Dosage Adjustments
Doctors may adjust the dose depending on:
- Blood sugar levels and diabetes status
- Liver function tests
- Severity of side effects or adverse reactions
Side Effects of Piqray 150mg
Like all cancer medicines, Piqray may cause side effects.
Common Side Effects
- High blood sugar (hyperglycemia)
- Diarrhea or nausea
- Fatigue and weakness
- Rash or skin reactions
Serious Side Effects
Liver Toxicity: Elevated liver enzymes requiring monitoring
Severe Hyperglycemia: Risk of diabetic complications
Pneumonitis: Rare lung inflammation
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Frequently Asked Questions (FAQs)
1. What is Piqray (Alpelisib) 150mg used for?
Piqray is used to treat HR-positive, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer in adults.
2. Is Alpelisib chemotherapy?
No. Alpelisib is a targeted therapy that blocks the PI3K-alpha pathway rather than traditional chemotherapy.
3. Can Alpelisib cure breast cancer?
Alpelisib is not a cure but helps slow tumor progression and enhance the effects of hormonal therapy in eligible patients.
4. How is PIK3CA mutation detected?
Doctors perform genetic or molecular testing on tumor tissue to identify PIK3CA mutations.
5. Is Alpesib 150mg the same as Piqray?
Alpesib 150mg contains Alpelisib, the same active ingredient found in Piqray. Generic versions is available. for more info. contact on WhatsApp: https://wa.me/8801742433764
6. Do I need a prescription to buy Alpesib (Alpelisib) 150mg?
Yes. Alpesib 150mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
Medical Disclaimer
Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Piqray (Alpelisib) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.
